The size of the European Enteral Feeding Devices Market was worth USD 0.62 billion in 2021. It is estimated to be growing at a CAGR of 5.24%, to reach USD 0.80 billion by 2026.
Enteral feeding devices are essential for people suffering from medical ailments such as swallowing disorders, digestive disorders, neurological disorders, cancer, etc.
Advances in technology have also led to compact and portable enteral feeding pumps constructed with materials that prevent cracking in high-stress applications. The pumps' advanced functions include appropriate programming options, scheduled flushing intervals, multilingual options, occlusion pressure alarm options, history of previous advance rates and tamper-evident display functions, and program lock. Improvements in pump design (in line with the requirements of healthcare providers and patients) and growth in the home care market (allowing enteral feeding of nutrients to home patients) drive the development of the enteral feeding devices market.
Over the next five years, declining federal funding and subsequent reductions in reimbursement for home health care services are expected to add to players' challenges in the enteral feeding device market.
The utility goods segment is primarily fueled by increased financial incentives and regulatory support from governments worldwide. The current enteral feeding devices owned by the utility company are affected mainly by the COVID-19 pandemic. Most German projects are behind schedule, and companies face short-term operational issues due to supply chain limitations and lack of site access due to the COVID-19 outbreak.
This research report on the European Enteral Feeding Devices Market has been segmented and sub-segmented into the following categories:
By Product Type:
By Stage:
By Application:
By End User:
By Country:
Regional Analysis:
Geographically, the European market is forecasted to experience significant growth in the coming years due to the increasing prevalence of infections and chronic diseases, especially in Europe and developing countries. Chronic diseases such as cancer and diabetes are one of the leading causes of death in Europe. Over 65% of people aged 65 and through suffer from at least one chronic disease. Over the past twenty years, the demand for enteral nutrition has increased rapidly. It is estimated that 35 percent of all patients in Europe suffer from malnutrition. Clinical nutrition is divided into clinical parenteral and enteral nutrition. Both types of nutrition are used for patients who cannot meet their nutritional needs by eating normally, for example, malnutrition. The enteral food market in Europe is growing, unlike the European enteral nutrition device market, which is mature and saturated.
In Europe, the enteral food market leader is Royal Numico NV, Novartis AG, and Abbott Laboratories Ltd are second and third, respectively. Fresenius Kabi AG is fourth in this market. Nestlé is fifth. Worldwide, Abbott Laboratories Ltd is number one in this market due to its presence in the United States. Novartis AG is second. Abbott Laboratories Ltd, Novartis AG, and Royal Numico NV are all located in Eastern Europe. Northern Europe is a large and well-established market (Germany, United Kingdom, and the Netherlands). Although these countries are not developing as fast, it is necessary that companies can continue to grow in stable markets. It is where the growth potential is essential. Per capita consumption in Germany, the United Kingdom, and the Netherlands is the highest. Southern Europe is a rapidly growing market (France, Spain, and Italy). They have displayed growth over the past four to five years. Surfacing markets in Eastern Europe are much trivial but show higher growth.
Strict remuneration regulations across the healthcare spectrum in Europe are likely to harm the incorporation of enteral foods by hospitals. However, adequate reimbursement, especially in the growing home care sector, aims to boost enteral feeding product adoption levels. Reimbursement regulations, such as the legislation in force in Germany in October 2015, have reduced illnesses/conditions for patients entitled to reimbursable enteral nutrition (28 illnesses down to 5). Consequently, hospital activity and investments, and innovations in this field by manufacturers are negatively affected.
Key players operating in Europe Enteral Feeding Devices Market profiled in this report are Halyard Health Inc., C. R. Bard, Inc., Abbott Laboratories, Fresenius SE, Covidien PLC, Cook Medical, and Nestle S.A.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 By Enteral Feeding Tubes
5.1.1.1 Nasoenteric Feeding Tubes
5.1.1.2 Oroenteric Feeding Tubes
5.1.1.3 Enterostomy Tubes
5.1.2 Giving Sets
5.1.3 Enteral Feeding Pumps
5.1.4 Administration Reservoirs
5.1.5 Enteral Syringes
5.1.6 Others
5.2 By Stage
5.2.1 Adults
5.2.2 Paediatrics
5.3 By Application
5.3.1 Gastroenterology
5.3.2 Neurological Disorders
5.3.3 Oncology
5.3.4 Diabetes
5.3.5 Hyper metabolism
5.4 By End User
5.4.1 Ambulatory Care Services
5.4.2 Hospitals
5.4.3 Others
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Halyard Health Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 C. R. Bard Inc.
8.3 Abbott Laboratories
8.4 Fresenius SE
8.5 Covidien PLC
8.6 Cook Medical
8.7 Nestle S.A
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
